DECEMBER 5, 2011
UCSF, GE Healthcare Team Up on Pioneering Cord Blood Project
Read article at http://www.ucsf.edu/news/2011/12/11067/ucsf-ge-healthcare-team-pioneering-cord-blood-project
APRIL 13, 2011
UCSF Team on Trail of Prion Treatment
Read article at http://abclocal.go.com/kgo/story?section=news/health&id=8069144
July 21, 2010
Anti-parasitic Drugs for Neglected Chagas Disease are in the worksRead article at http://www.ucsf.edu/news/2010/07/5997/chagas-disease-parasite-t-cruzi-focus-new-drug-development-negle
February 18, 2010
UCSF enters drug discovery agreement with Genentech
Read article
at http://news.ucsf.edu/releases/ucsf-enters-drug-discovery-agreement-with-genentech/
October 15, 2009
UCSF Researchers Join Consortium to Target Cancer in New Ways
Read article
at http://pharmacy.ucsf.edu/news/2009/10/15/1/
July 15, 2009
UCSF researchers help crack parasite genome, identify drug leads
Read article
at http://news.ucsf.edu/releases/ucsf-researchers-help-crack-parasite-genome-identify-drug-leads/
October 27, 2006
Jim Wells: Helping to Fill the Drug Discovery Pipeline
Read article
at http://pub.ucsf.edu/today/cache/news/200610265.html
April 7, 2006
The University of California, San Francisco (UCSF) has entered into a research and license agreement with Sunesis Pharmaceuticals, a biopharmaceutical company located in South San Francisco.
Under the terms of the agreement, the Small Molecule Discovery Center (SMDC) at UCSF is granted a limited license to utilize Sunesis' fragment-based drug discovery technology Tethering®, for academic purposes. The SMDC intends to leverage Sunesis' technology to identify novel small molecule drug candidates. In return, Sunesis receives an exclusive royalty-free license to any improvements to the Sunesis technology or fragment libraries that emerge from the SMDC's research. In the event that any small molecules are discovered using Sunesis' technology, Sunesis will have a right of first negotiation to in-license the compounds.
